Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) is approaching a key milestone in its proposed acquisition of Planet 13 Holdings Inc., with Planet 13 shareholders scheduled to vote on the transaction December 10.
The upcoming vote follows Vireo’s third-quarter 2026 results, released November 10, which included $253.7 million in revenue, a 177% increase from the same period last year, and $42.7 million in adjusted EBITDA.
The figures reflect Vireo’s rapid acquisition-driven expansion. The company has completed several transactions this year, including its November 9 acquisition of FLUENT, while other deals, including Planet 13, remain pending.
The proposed Planet 13 merger would add another significant group of cannabis assets to a company that already generates more than $1 billion in annualized revenue based on its latest quarterly results.
Planet 13 Shareholders Face December 10 Vote
Vireo and Planet 13 announced their all-stock merger agreement in July.
The transaction is designed to expand Vireo’s presence in Nevada and Florida while adding operations in Illinois.
A November 10 securities filing identifies December 10 as the date of Planet 13’s special shareholder meeting to vote on the merger.
Shareholder approval would represent an important step toward completion, although the transaction remains subject to applicable closing conditions.
The timing is significant because Vireo’s operating footprint has continued changing since the acquisition was first announced.
Vireo Reports $254 Million in Revenue, but Margins Narrow Sequentially
Vireo’s third-quarter GAAP revenue rose to $253.7 million from $91.7 million a year earlier. Cannabis revenue accounted for $198.1 million, while non-cannabis revenue contributed $55.6 million.
The company reported $107.8 million in gross profit, representing a gross margin of 42.5%.
Adjusted EBITDA reached $42.7 million, up 68.1% year over year.
However, sequential comparisons provide a more nuanced picture of the company’s financial performance.
Revenue increased 21.2% from the second quarter, but adjusted EBITDA rose only 2.9%. Adjusted EBITDA margin declined from 19.8% to 16.8%, while gross margin fell from 45.5% to 42.5%.
The company ended September with $106.8 million in cash and approximately $293 million in long-term debt.
FLUENT Adds 33 Florida Dispensaries Before Planet 13 Deal
Vireo closed its acquisition of FLUENT on November 9, adding 33 dispensaries to its Florida operations.
The company also reported receiving federal Drug Enforcement Administration registrations for all 41 of its state-licensed medical cannabis dispensaries in Florida.
Those registrations are distinct from the pending Planet 13 acquisition, but they add another regulatory dimension to Vireo’s expanding Florida business.
Florida is particularly important because Vireo is assembling a larger retail and cultivation platform in one of the country’s biggest medical cannabis markets.
Planet 13 would bring additional Florida assets, along with its Nevada operations, into that growing portfolio if the merger closes.
The company’s acquisition strategy extends beyond those two states. Vireo has also announced or completed transactions involving operations in Colorado, Illinois, Massachusetts, New Jersey, Ohio and Pennsylvania.
Upon completion of its announced transactions, Vireo expects to operate approximately 270 dispensaries across 15 states.
Vireo Forecasts Further Growth in Early 2027
Vireo’s latest financial outlook calls for fourth-quarter revenue between $250 million and $265 million, with adjusted EBITDA between $45 million and $48 million.
For the first quarter of 2027, the company projects revenue of $280 million to $300 million and adjusted EBITDA of $53 million to $56 million.
Both forecasts exclude acquisitions that remained pending as of November 10.
The fourth-quarter guidance includes FLUENT’s results beginning November 9, while the first-quarter forecast incorporates a full quarter of FLUENT operations.
Vireo estimates that acquisitions still awaiting completion could contribute another $50 million to $60 million in quarterly revenue and $7 million to $8 million in adjusted EBITDA if completed before the beginning of 2027.
The Next Test Is Integration
Vireo’s acquisition strategy is producing rapid increases in reported revenue and expanding its reach across state cannabis markets.
The company has also begun reporting indicators of underlying operating performance. Management cited 4% pro forma year-over-year retail revenue growth during the third quarter as a proxy for same-store sales growth.
That measure offers a different perspective from the 177% increase in reported revenue, which was heavily influenced by acquisitions.
Vireo’s ability to create value from its growing portfolio will depend on improving the performance of acquired businesses, managing debt and integration costs, and converting additional sales into sustainable earnings and cash flow.
The December 10 Planet 13 shareholder vote will determine whether one of the company’s largest announced consolidation moves advances toward completion.
Until then, Planet 13 remains a prospective addition to Vireo’s business, rather than part of its reported operating results. The broader implications of cannabis consolidation will be among the topics discussed at IgniteIt’s Cannabis Capital & Policy Summit in Washington, D.C., on November 18, bringing together industry executives, investors and policymakers.

